US Market Report for Blood Glucose Test Strips 2017 – MedCore – Research and Markets

DUBLIN--(BUSINESS WIRE)-- Research and Markets has announced the addition of the "US Market Report for Blood Glucose Test Strips 2017 - MedCore" report to their offering.

The U.S. blood glucose test strip market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose test strip market was the personal segment. Personal test strips are used by individuals who use personal meters to perform self-monitoring of blood glucose (SMBG) on a daily basis.

The personal test strip market is further segmented by insurance type and comprises the Medicare/Medicaid, managed care and cash sub-segments. CMS competitive bidding had a significant impact on the personal test strip market after substantial reimbursement cuts in July 2013 and July 2016, respectively.

Professional test strips are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Meters in the hospital are typically more technologically advanced than meters found in other settings and often involve software systems which analyze data and provide higher accuracy than personal meters.

The growing number of individuals living in nursing homes or other long term care facilities who have diabetes will be the primary driver of market growth. However, as assisted living is becoming more popular, patients are opting for their own personal meters. Long term care centers are also starting to enforce one patient-one meter' policies, shifting the focus away from professional meters and test strips.

Key Topics Covered:

Table Of Contents I

List Of Figures Iii

List Of Charts V

Executive Summary

U.S. Diabetes Monitoring, Treatment And Drug Delivery Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedure Numbers

Procedure Codes Investigated

Markets Included

Key Report Updates

Version History

Research Methodology

Companies Mentioned

Sanofi

Novo Nordisk

Eli Lilly

Medtronic

Johnson & Johnson

Becton Dickinson

Abbott

Roche

DexCom

Ascensia

Insulet

Trividia Health

Tandem

Nova Biomedical

Valeritas

For more information about this report visit http://www.researchandmarkets.com/research/xxjbxt/us_market_report

View source version on businesswire.com: http://www.businesswire.com/news/home/20161117005548/en/

Research and Markets

Laura Wood, Senior Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Topics: Medical Devices, Glucose Testing, Diabetes Devices

Source: Research and Markets